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We conducted a three-stage genetic study to identify 
susceptibility loci for type 2 diabetes (T2D) in east Asian 
populations. We followed our stage 1 meta-analysis of eight 
T2D genome-wide association studies (6,952 cases with T2D 
and 11,865 controls) with a stage 2 in silico replication  
analysis (5,843 cases and 4,574 controls) and a stage 3 de novo  
replication analysis (12,284 cases and 13,172 controls).  
The combined analysis identified eight new T2D loci reaching 
genome-wide significance, which mapped in or near GLIS3, 
PEPD, FITM2-R3HDML-HNF4A, KCNK16, MAEA, GCC1-PAX4, 
PSMD6 and ZFAND3. GLIS3, which is involved in pancreatic 
beta cell development and insulin gene expression1,2, is known  
for its association with fasting glucose levels3,4. The evidence of 
an association with T2D for PEPD5 and HNF4A6,7 has been  
shown in previous studies. KCNK16 may regulate glucose-
dependent insulin secretion in the pancreas. These findings, 
derived from an east Asian population, provide new 
perspectives on the etiology of T2D.
T2D is a major public health problem with a rapidly rising global 
prevalence8. The development of T2D is influenced by diverse factors, 
and decades of epidemiological studies have linked obesity, hyper-
tension and dyslipidemia with the risk of T2D9. It is also known that 
T2D has considerable heritability. Within only the last 3 years, genetic 
studies have produced a rapidly lengthening list of loci harboring 
disease-predisposing variations10. To date, genetic variants at 45 loci 
have been identified for T2D10,11. Despite these advances toward a 
better understanding of the genetic basis of T2D, its heritability has 
not been fully explained12. In addition, most of the T2D loci were 
detected initially in population samples of European origin, with the 
exceptions of KCNQ1, UBE2E2 and C2CD4A-C2CD4B, which were 
first identified in studies of east Asian populations13–15. Additional 
efforts involving east Asian populations identified variants associated 
with T2D at the SPRY2, PTPRD and SRR loci5,16,17. However, these 
associations need more validation from additional studies of east 
Asians as well as in studies of other populations. A large meta-analysis 
in east Asians would be expected to identify new genetic associations 
and provide insights into T2D pathogenesis. In addition to differences 
in the allele frequencies between east Asians and Europeans, which 
may affect the power to detect associations in these populations, T2D 
epidemiology also differs considerably between European populations 
and east Asian populations. In east Asians, the rates of diabetes are 
often higher at lower average body mass indices (BMIs)18, suggesting 
that some different pathways may be involved in pathogenesis of T2D 
in east Asians and Europeans.
To discover new T2D loci, we conducted a three-stage association 
study in individuals of east Asian descent (Supplementary Fig. 1). 
We performed the stage 1 meta-analysis by combining eight T2D 
genome-wide association studies (GWAS) participating in the Asian 
Genetic Epidemiology Network (AGEN) consortium (6,952 cases 
and 11,865 controls) with association data for 2,626,356 imputed and 
genotyped autosomal SNPs, and we used the inverse-variance method 
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for fixed effects for the statistical analyses (Supplementary Table 1). 
All imputed and genotyped SNPs (minor allele frequency (MAF) > 
0.01) passed quality control filters in each of the eight stage 1 datasets 
prior to conducting the meta-analysis (Supplementary Table 2). The 
genomic control inflation factor (λ) for the meta-analysis was 1.046 
(and was less than 1.062 for each of the individual studies), indicat-
ing that the results seen in stage 1 were probably not the result of 
population stratification (Supplementary Fig. 2). Individuals from 
each component study that participated in stage 1 mainly clustered 
together with the samples from the CHB/JPT HapMap population 
in the principal component analysis plot (Supplementary Fig. 3), 
further showing the similarity in ethnicity between the stage 1 samples. 
Most signals showing strong evidence for T2D associations were 
in known T2D genes (Fig. 1). Stage 1 P values, odds ratios (ORs) 
and average risk allele frequencies for 45 previously reported T2D- 
associated SNPs are listed in Supplementary Table 3.
After removing known T2D variants, we selected 297 SNPs from 
independent loci from the stage 1 meta-analysis based on our arbi-
trary inclusion criteria for in silico follow-up replication: meta-analysis 
P < 5 × 10−4 (based on the divergence between the observed and 
expected P values on the quantile-quantile plot; Supplementary 
Fig. 2), heterogeneity P > 0.01 and at least seven studies having been 
included in the meta-analysis (Supplementary Table 4). We took a 
total of 3,756 SNPs, including the 297 selected SNPs and their proxies 
(r2 > 0.8 based on phase 2 CHB/JPT HapMap data), forward to stage 2 
(in silico replication) in three independent GWAS (5,843 cases and 
4,574 controls). After a meta-analysis that combined stage 1 and 
2 data for 3,756 SNPs, we selected the 19 SNPs that showed the 
most compelling evidence for association (stage 1 and 2 combined 
P < 10−5) (Supplementary Table 5) for stage 3 de novo genotyping in 
up to 12,284 cases and 13,172 controls recruited from five independ-
ent studies (Supplementary Tables 1 and 2). This resulted in eight 
new T2D loci that reached genome-wide significance in the combined 
meta-analysis across all three stages (Table 1 and Fig. 2).
Three of these T2D-associated loci were previously associated with 
metabolic traits or related diseases or were suggestively associated 
with T2D. We detected one such locus within an intron of GLIS3, 
a gene that is highly expressed in islet beta cells. The coding prod-
uct of this gene, a Krüppel-like zinc finger transcription factor, has 
been proposed as a key player in the regulation of pancreatic beta cell 
development and insulin gene expression1,2. SNPs in high linkage 
disequilibrium (LD) with this locus have been implicated in asso-
ciation with type 1 diabetes (T1D)19 and fasting plasma glucose3. 
The second such locus, on 19q13, is located in an intron of PEPD. 
Several SNPs (lead SNP: rs10425678) in this gene were previously 
associated with T2D in a Japanese population5. However, the SNP 
in PEPD identified in our study (rs3786897) is not in LD with those 
identified in the Japanese population (r2 = 0.008, D′ = 0.143 between 
rs3786897 and rs10425678 based on phase 
2 CHB/JPT HapMap data), and our GWAS 
data do not support an association for T2D 
with rs10425678 (P = 0.528). The third such 
signal is near FITM2-R3HDML-HNF4A. 
FITM2 may be involved in lipid droplet accu-
mulation20, and the function of R3HDML 
is not known. Mutations in HNF4A cause 
maturity onset diabetes of the young type 1 
(ref. 21). Common variants in the P2 pro-
moter region of this gene (rs1884613 and 
rs2144908) have been associated with T2D 
in a population-specific manner6,22. The SNP 
near FITM2-R3HDML-HNF4A identified in our study (rs6017317) is 
not in strong LD with the HNF4A P2 promoter SNPs (r2 = 0.23–0.25, 
D′ = 0.50–0.54 between rs6017317 and rs1884613 or rs2144908 based 
on phase 2 CHB/JPT HapMap data), indicating that rs6017317 is a 
new T2D signal in the 20q13.12 region where HNF4A resides.
The other five loci reaching genome-wide significance in our 
study have not previously been reported in the context of any meta-
bolic traits, including the loci mapped in or near KCNK16, MAEA, 
GCC1-PAX4, PSMD6 and ZFAND3. KCNK16, which is expressed 
predominantly in the pancreas, encodes a potassium channel pro-
tein containing two pore-forming P domains23. In pancreatic β cells, 
potassium channels that are inhibited by ATP regulate glucose-
dependent insulin secretion. Among the variants in strong LD with 
the signal reaching genome-wide significance in KCNK16 (rs1535500) 
is rs11756091 (r2 = 0.977, D′ = 1.0 based on phase 2 CHB/JPT HapMap 
data), which encodes a substitution of proline to histidine in two 
isoforms of KCNK16. This variant or others influencing KCNK16 
may result in the defective regulation of potassium channel activity 
that contributes to the etiology of T2D24. MAEA encodes a protein 
that has a role in erythroblast enucleation and in the development 
of mature macrophages25. A gene-set analysis of the stage 1 P values 
using GSA-SNP26 indicated that MAEA belongs to a group of genes 
that previously showed significant association with T2D and includes 
IDE, which is located at a known T2D susceptibility locus27 (stage 1 
P = 1.41 × 10−7 for rs6583826 at the IDE locus in this study). The 
GRIP-domain–containing protein that is encoded by GCC1 might 
have a role in the organization of the trans-Golgi network, which is 
involved in membrane transport28. PAX4, which is only 30 kb away 
from GCC1, is a good candidate for T2D given its involvement in 
pancreatic islet development. PAX4 was recently implicated in a 
Japanese individual with maturity onset diabetes of the young29. The 
expression product of PSMD6, which acts as a regulatory subunit 
of the 26S proteasome, is probably involved in the ATP-dependent 
degradation of ubiquitinated proteins30. Although the function of 
ZFAND3 has not been fully elucidated, it is noteworthy that a member 
of the same gene family, ZFAND6, is present along with FAH at a 
previously detected T2D locus31. We examined whether eight new loci 
are potentially associated with T2D through an effect on obesity, as 
is the case with FTO32. All of the T2D association signals we initially 
detected remained after adjustment for BMI (Supplementary Table 6), 
indicating that the associations with T2D of these eight loci are not 
mediated through an effect on obesity.
In addition to the eight loci reaching genome-wide significance, we 
identified two loci showing moderate evidence (combined P < 10−6) 
of association with T2D, including WWOX and CMIP loci (Table 1). 
We obtained the association results for these ten loci in GWAS data 
from up to 47,117 European samples generated by the DIAGRAM 
consortium (DIAGRAM+ is the current version of dataset)31. 
16
1 2 3 4 5 6 7 8 9 10 11 12 13
Chromosome
IGF2BP2
CDKAL1 CDKN2A/2B KCNQ1
SLC30A8
HHEX/IDE
KCNJ11 FTO
14 15 16 171819 20 2122
–l
og
10
 P
8
0
Figure 1 Genome-wide Manhattan plot for the east Asian T2D stage 1 meta-analysis. Shown are 
the –log10 P values using the trend test for SNPs distributed across the entire autosomal genome. 
The red dots at each locus indicate the signals with P < 10−6 detected in the genome-wide meta-
analysis. A total of 1,934,619 SNPs that were present in at least five stage 1 studies were used to 
generate the plot.
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The DIAGRAM-generated results for these loci indicated that three loci, 
including the FITM2-R3HDML-HNF4A (rs6017317: P = 1.47 × 10−2, 
OR = 1.07), CMIP (rs16955379: P = 3.33 × 10−2, OR = 1.20) and 
MAEA (using the proxy SNP for rs6815464, rs11247991 (r2 = 0.96): 
P = 6.56 × 10−3, OR = 1.19) loci, were modestly associated with T2D, 
whereas a locus in GLIS3 (rs7041847: P = 6.43 × 10−2, OR = 1.04) was 
nominally associated with T2D. The direction of effect was consistent 
in four (PSMD6, PEPD, WWOX and KCNK16) of the six loci that were 
not replicated in DIAGRAM+ (Supplementary Table 5).
We analyzed the functional connections among the 10 new T2D 
genes and the 28 known T2D genes that we replicated in this study 
(Supplementary Table 3) using GRAIL33. The connection results 
highlighted notable biological functions for sets of genes within 
T2D-associated regions (Supplementary Fig. 4 and Supplementary 
Tables 7 and 8). For example, KCNK16 has strong connections with 
previously known T2D genes encoding potassium channels (KCNJ11 
and KCNQ1), implying that is has a physiological role in the regula-
tion of potassium transport in pancreatic cells.
We examined the association between each new T2D SNP and 
the expression of genes within 1 Mb of these SNPs by an expres-
sion quantitative trait locus (eQTL) analysis using the data from the 
MuTHER consortium. One SNP (rs3786897) in an intron of PEPD 
was highly associated with the mRNA expression of PEPD in the adi-
pose tissue of 776 individuals of European ancestry (PeQTL = 2.14 × 
10−8) (Supplementary Table 9). However, this SNP did not show an 
association with T2D in populations of European ancestry, thus the 
importance of this finding is unclear.
We considered the possibility that autoimmune diabetes (rather 
than T2D) may be driving some of the signals that we observed. 
First, the cases from all the studies we examined predominantly had 
adult-onset diabetes (age of disease onset ≥30 years), and none of 
the clinically diagnosed subjects had T1D, which is defined by the 
presence of acute ketosis and the continuous requirement of insulin 
beginning within 1 year after diagnosis. Second, we researched the 
associations for all known T1D-associated variants in our dataset. 
Only a small number of loci showed association after this analysis 
(Supplementary Table 10). These results are in distinct contrast to 
those for known T2D-associated variants, many of which replicated 
in our study (Supplementary Table 3), further suggesting that our 
findings are most relevant to T2D. Third, as variants close to the 
GLIS3 locus have been shown to be associated with T1D19, we exam-
ined the association between rs7041847 and diabetes in four studies 
(n = 8,383) in which individulas with positive glutamic acid decar-
boxylase (GAD) antibodies had been excluded (as individuals with 
T1D are positive for GAD antibodies, whereas individuals with T2D 
are not) (data not shown). In each study, the associations between 
this SNP and diabetes were the same as the association found when 
we included all the samples (meta-analysis P = 3.4 × 10−4, OR = 1.12). 
This finding, along with the fact that SNPs at the GLIS3 locus also 
show associations with fasting plasma glucose in nondiabetic adults3 
and in healthy children and adolescents4, is consistent with the 
hypothesis that SNPs at this locus may affect fasting glucose home-
ostasis rather than the immune system. Taken together, it is unlikely 
that a substantial proportion of the positive associations observed in 
our study were driven by autoimmune diabetes.
This study is the largest GWAS meta-analysis, to our knowledge, 
conducted for T2D in east Asians. Findings from this study high-
light not only previously unknown biological pathways but also 
population-specific loci for T2D. The association of rs9470794 
in ZFAND3 with T2D seems to be highly specific to east Asian 
populations (Supplementary Table 5), whereas the association of ta
bl
e 
1
 e
ig
ht
 n
ew
 t
2
D
 lo
ci
 r
ea
ch
in
g 
ge
no
m
e-
w
id
e 
si
gn
if
ic
an
ce
 f
ro
m
 a
 c
om
bi
ne
d 
m
et
a-
an
al
ys
is
 o
f 
st
ag
es
 1
, 2
 a
nd
 3
S
N
P
C
hr
.
P
os
it
io
n 
(b
p)
N
ea
rb
y 
ge
ne
R
is
k 
 
al
le
le
O
th
er
  
al
le
le
S
ta
ge
 1
 (
di
sc
ov
er
y)
a
S
ta
ge
 2
 (
in
 s
ili
co
 r
ep
lic
at
io
n)
b
S
ta
ge
 3
 (
de
 n
ov
o 
re
pl
ic
at
io
n)
c
C
om
bi
ne
d 
(s
ta
ge
s 
1
, 
2
 a
nd
 3
)d
O
R
 (
9
5
%
 C
I)
P
O
R
 (
9
5
%
 C
I)
P
O
R
 (
9
5
%
 C
I)
P
O
R
 (
9
5
%
 C
I)
P
Lo
ci
 s
ho
w
in
g 
st
ro
ng
 e
vi
de
nc
e 
of
 a
ss
oc
ia
ti
on
 w
it
h 
T2
D
rs
6
8
1
5
4
6
4
4
1
,2
9
9
,9
0
1
M
AE
A
C
G
1
.0
9
 (
1
.0
4
–1
.1
4
)
8
.2
1
 ×
 1
0
−
4
1
.1
3
 (
1
.0
7
–1
.2
0
)
3
.6
7
 ×
 1
0
−
5
1
.1
6
 (
1
.1
1
–1
.2
0
)
4
.1
5
 ×
 1
0
−
1
5
1
.1
3
 (
1
.1
0
–1
.1
6
)
1
.5
7
 ×
 1
0
−
2
0
rs
7
0
4
1
8
4
7
9
4
,2
7
7
,4
6
6
G
LI
S3
A
G
1
.0
9
 (
1
.0
4
–1
.1
4
)
1
.2
9
 ×
 1
0
−
4
1
.0
9
 (
1
.0
3
–1
.1
5
)
2
.2
0
 ×
 1
0
−
3
1
.1
1
 (
1
.0
7
–1
.1
5
)
2
.8
9
 ×
 1
0
−
9
1
.1
0
 (
1
.0
7
–1
.1
3
)
1
.9
9
 ×
 1
0
−
1
4
rs
6
0
1
7
3
1
7
2
0
4
2
,3
8
0
,3
8
0
FI
TM
2-
R
3H
D
M
L-
H
N
F4
A
G
T
1
.1
0
 (
1
.0
5
–1
.1
5
)
2
.4
3
 ×
 1
0
−
5
1
.0
7
 (
0
.9
9
–1
.1
5
)
8
.4
2
 ×
 1
0
−
2
1
.1
0
 (
1
.0
6
–1
.1
4
)
3
.9
6
 ×
 1
0
−
7
1
.0
9
 (
1
.0
7
–1
.1
2
)
1
.1
2
 ×
 1
0
−
1
1
rs
6
4
6
7
1
3
6
7
1
2
6
,9
5
2
,1
9
4
G
CC
1-
PA
X4
G
A
1
.1
2
 (
1
.0
6
–1
.1
8
)
6
.4
7
 ×
 1
0
−
5
1
.1
1
 (
1
.0
4
–1
.1
8
)
2
.0
9
 ×
 1
0
−
3
1
.1
0
 (
1
.0
5
–1
.1
5
)
2
.3
1
 ×
 1
0
–5
1
.1
1
 (
1
.0
7
–1
.1
4
)
4
.9
6
 ×
 1
0
–1
1
rs
8
3
1
5
7
1
3
6
4
,0
2
3
,3
3
7
PS
M
D
6
C
T
1
.1
1
 (
1
.0
6
–1
.1
7
)
4
.8
5
 ×
 1
0
–6
1
.0
6
 (
1
.0
0
–1
.1
3
)
4
.4
6
 ×
 1
0
–2
1
.0
8
 (
1
.0
5
–1
.1
2
)
1
.4
1
 ×
 1
0
–5
1
.0
9
 (
1
.0
6
–1
.1
2
)
8
.4
1
 ×
 1
0
–1
1
rs
9
4
7
0
7
9
4
6
3
8
,2
1
4
,8
2
2
ZF
AN
D
3
C
T
1
.1
1
 (
1
.0
5
–1
.1
7
)
1
.4
5
 ×
 1
0
–4
1
.0
9
 (
1
.0
2
–1
.1
7
)
1
.4
8
 ×
 1
0
–2
1
.1
6
 (
1
.0
9
–1
.2
3
)
3
.2
0
 ×
 1
0
–6
1
.1
2
 (
1
.0
8
–1
.1
6
)
2
.0
6
 ×
 1
0
–1
0
rs
3
7
8
6
8
9
7
1
9
3
8
,5
8
4
,8
4
8
PE
PD
A
G
1
.1
4
 (
1
.0
8
–1
.2
0
)
3
.7
4
 ×
 1
0
–6
1
.0
5
 (
0
.9
9
–1
.1
2
)
1
.2
8
 ×
 1
0
–1
1
.1
1
 (
1
.0
4
–1
.1
7
)
5
.4
6
 ×
 1
0
–4
1
.1
0
 (
1
.0
7
–1
.1
4
)
1
.3
0
 ×
 1
0
–8
rs
1
5
3
5
5
0
0
6
3
9
,3
9
2
,0
2
8
K
CN
K
16
T
G
1
.1
1
 (
1
.0
6
–1
.1
6
)
5
.3
4
 ×
 1
0
–6
1
.0
7
 (
1
.0
1
–1
.1
5
)
3
.3
3
 ×
 1
0
–2
1
.0
6
 (
1
.0
2
–1
.1
0
)
3
.5
0
 ×
 1
0
–3
1
.0
8
 (
1
.0
5
–1
.1
1
)
2
.3
0
 ×
 1
0
–8
Lo
ci
 s
ho
w
in
g 
m
od
er
at
e 
ev
id
en
ce
 o
f 
as
so
ci
at
io
n 
w
it
h 
T2
D
rs
1
6
9
5
5
3
7
9
e
1
6
8
0
,0
4
6
,8
7
4
CM
IP
C
T
1
.1
3
 (
1
.0
7
–1
.2
0
)
2
.2
0
 ×
 1
0
–5
1
.1
0
 (
1
.0
3
–1
.1
7
)
6
.5
9
 ×
 1
0
–3
1
.0
5
 (
1
.0
1
–1
.1
0
)
2
.1
9
 ×
 1
0
–2
1
.0
8
 (
1
.0
5
–1
.1
2
)
2
.8
4
 ×
 1
0
–7
rs
1
7
7
9
7
8
8
2
1
6
7
7
,9
6
4
,4
1
9
W
W
O
X
T
C
1
.1
2
 (
1
.0
5
–1
.1
8
)
1
.7
6
 ×
 1
0
–4
1
.0
9
 (
1
.0
2
–1
.1
6
)
1
.2
1
 ×
 1
0
–2
1
.0
6
 (
1
.0
1
–1
.1
1
)
1
.6
1
 ×
 1
0
–2
1
.0
8
 (
1
.0
5
–1
.1
2
)
9
.4
9
 ×
 1
0
–7
a U
p 
to
 6
,9
5
2
 c
as
es
 a
nd
 1
1
,8
6
5
 c
on
tr
ol
s.
 b
U
p 
to
 5
,8
4
3
 c
as
es
 a
nd
 4
,5
7
4
 c
on
tr
ol
s.
 c
U
p 
to
 1
2
,2
8
4
 c
as
es
 a
nd
 1
3
,1
7
2
 c
on
tr
ol
s.
 d
U
p 
to
 2
5
,0
7
9
 c
as
es
 a
nd
 2
9
,6
1
1
 c
on
tr
ol
s.
 e
Th
e 
pr
ox
y 
S
N
P
 r
s9
9
3
0
1
1
7
 (
r2
 =
 1
) 
w
as
 g
en
ot
yp
ed
 in
 t
he
 
st
ag
e 
3
 C
A
G
E
 s
tu
dy
.
©
 2
01
2 
N
at
u
re
 A
m
er
ic
a,
 In
c.
  A
ll 
ri
g
h
ts
 r
es
er
ve
d
.
70  VOLUME 44 | NUMBER 1 | JANUARY 2012 Nature GeNetics
l e t t e r s
rs11634397 near ZFAND6 seems to be specific to European popula-
tions (Supplementary Table 3). We observed a substantial difference 
in the risk allele frequencies of both loci between the two continental 
(Asian and European) populations (rs9470794: risk allele frequency 
(RAF) = 0.32 for the Asian CHB/JPT HapMap population compared to 
RAF = 0.12 for the European CEU HapMap population; rs11634397: 
RAF = 0.07 for CHB/JPT compared to RAF = 0.64 for CEU). Although 
these loci are related to T2D differently in the two populations (the 
ZFAND3 locus is specific to Asians, whereas the ZFAND6 locus to 
Europeans), these results lead to speculation that the broader A20 
domain-containing zinc finger protein family has a role in the etiology 
of T2D. Additional population-specific T2D loci were also suggested 
by our analysis, for example, WWOX (rs17797882) (Supplementary 
Table 5) in east Asians and ZBED3 (rs4457053) (Supplementary 
Table 3) in Europeans. Despite the lack of clear physiological evi-
dence on T2D pathogenesis, these findings may provide clues to 
help understand T2D phenotypes characteristic of each population, 
for example, the high rates of diabetes seen at lower average BMIs 
in east Asians.
URLs. IMPUTE, http://mathgen.stats.ox.ac.uk/impute/impute.html; 
MACH, http://www.sph.umich.edu/csg/abecasis/MACH/; BEAGLE, 
http://faculty.washington.edu/browning/beagle/beagle.html; METAL, 
http://www.sph.umich.edu/csg/abecasis/Metal; WGAViewer, http://
compute1.lsrc.duke.edu/softwares/WGAViewer/; SNAP, http://www.
broadinstitute.org/mpg/snap/; LocusZoom, http://csg.sph.umich.
edu/locuszoom/; GenABEL, http://www.genabel.org/; ProbABEL, 
http://www.genabel.org/packages/ProbABEL.
MeThoDs
Methods and any associated references are available in the online 
version of the paper at http://www.nature.com/naturegenetics/.
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Figure 2 Regional association plots for new T2D loci. a–j At the top, the positions of SNPs are 
shown, and in the middle, the regional association results from the genome-wide meta-analysis 
are shown. The trend test –log10 P values are shown for SNPs distributed in a 0.8-Mb genomic 
region centered on the most strongly associated signal, which is depicted as a purple diamond 
for the stage 1 results and a red diamond for the combined stage 1, 2 and 3 results. At the 
bottom, the locations of known genes in the region are shown. The genetic information was 
from the Human Genome build hg18, and the LD structure was based on the 1000 Genomes 
Project JPT+CHB data (June 2010).
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Note: Supplementary information is available on the Nature Genetics website.
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Study subjects. Stage 1 subjects were drawn from eight T2D GWAS par-
ticipating in the AGEN consortium, which was organized to enable genetic 
studies on diverse complex traits in 2010. These eight studies included 6,952 
cases with T2D and 11,865 controls from the Korea Association Resource 
Study (KARE), the Singapore Diabetes Cohort Study (SDCS), the Singapore 
Prospective Study Program (SP2), the Singapore Malay Eye Study (SiMES), 
the Japan Cardiometabolic Genome Epidemiology Network (CAGE), the 
Shanghai Diabetes Genetic Study (SDGS), the Taiwan T2D Study (TDS) and 
the Cebu Longitudinal Health and Nutritional Survey (CLHNS). Subjects in 
stage 2 included 5,843 cases with T2D and 4,574 controls from three inde-
pendent GWAS, the BioBank Japan Study (BBJ), the Health2 T2D Study 
(H2T2DS) and the Shanghai Jiao Tong University Diabetes Study (SJTUDS), 
for in silico replication analysis. Stage 3 included up to 12,284 cases with T2D 
and 13,172 controls from five different studies, the Japan Cardiometabolic 
Genome Epidemiology Network (CAGE), the Shanghai Diabetes Study I/II 
(SDS I/II), the Chinese University of Hong Kong Diabetes Study (CUHKDS), 
the National Taiwan University Hospital Diabetes Study (NTUHDS) and the 
Seoul National University Hospital Diabetes Study (SNUHDS), for de novo 
replication analysis. The study design and T2D diagnosis criteria used in each 
study included in stages 1, 2, and 3 are described in Supplementary Table 1 
and the Supplementary Note. Each study obtained approval from the appro-
priate institutional review boards of each participating institution, and written 
informed consent was obtained from all participants. The three-stage design 
of the overall study is depicted in Supplementary Figure 1.
Genotyping and imputation. Subjects for the stage 1 and 2 analyses were 
genotyped with high-density SNP typing platforms that covered the entire 
human genome. In most of the studies, only unrelated samples with missing 
genotype call rates below 5% were included for subsequent GWAS analyses. 
For the genome-wide association meta-analysis, each study participating in 
stages 1 and 2 performed SNP imputation. IMPUTE, MACH or BEAGLE (see 
URLs) were used, together with haplotype reference panels from the JPT and 
CHB samples that are available in the HapMap database (JPT+CHB+CEU 
and/or YRI, in some studies) on the basis of HapMap build 36 (release 21, 
22, 23a or 24). Only imputed SNPs with high genotype information content 
(proper info > 0.5 for IMPUTE and Rsq > 0.3 for MACH and BEAGLE) were 
used for the association analysis. Genotyping for the stage 3 analysis was car-
ried out using TaqMan, Sequenom MassARRAY or the Beckman SNP Stream 
method. All SNPs included in stage 3 had a genotype success rate of >98% 
(Supplementary Table 2).
Statistical analyses, analysis tools and SNP prioritization for stages 2 and 3. 
Associations between SNPs and T2D were tested by logistic regression with 
an additive model (1 degree of freedom) after adjustment for sex. Other 
adjustments were permitted according to the situations in the individual 
studies. The meta-analysis was performed using an inverse-variance method 
assuming fixed effects, with a Cochran’s Q test to assess between-study 
heterogeneity. METAL software (see URLs) was used for all meta-analyses. 
A plot of the negative log of the association results from the stage 1 meta- 
analysis, by chromosome, was generated using WGAViewer software (see 
URLs).The quantile-quantile plot was constructed by plotting the distribu-
tion of observed P values for the given SNPs against the theoretical distri-
bution of the expected P values for T2D34. The genomic control inflation 
factor, λ, was calculated by dividing the median χ2 statistics by 0.456 (ref. 35) 
for individual GWAS, as well as for the stage 1 GWAS meta-analysis. We did 
not correct for genomic control in the stage 1 analyses because the infla-
tion was modest, suggesting that population structure is unlikely to cause 
substantial inflation of the stage 1 results (Supplementary Table 2). The 
selection criteria for the lead SNPs to take forward to stage 2 in silico repli-
cation analysis were as follows: (i) stage 1 meta-analysis P < 5 × 10−4 (based 
on the divergence between the observed and expected P values on the 
quantile-quantile plot; Supplementary Fig. 2); (ii) heterogeneity P > 0.01; 
and (iii) at least seven studies having been included in the stage 1 meta- 
analysis (Supplementary Table 4). After removing known variants associated 
with T2D, proxies for each lead SNP (r2 > 0.8) were selected using the SNAP 
software (see URLs). The replication genotyping for stage 3 was performed 
for the new SNPs having a stage 2 combined P < 10−5. Regional association 
results from genome-wide meta-analysis were plotted using LocusZoom 
software (see URLs) for SNPs reaching genome-wide significance from the 
combined meta-analysis of stages 1, 2 and 3.
Principal components analysis. A list of 76,534 common SNPs across the 
Illumina 550, 610 and 1M and Affymetrix 5.0 and 6.0 arrays were first selected. 
This set of SNPs in the Asian (CHB+JPT) HapMap II samples was then trained 
to generate a list of 44,524 SNPs having pairwise LD < 0.3 in a sliding window 
of 50 SNPs. Individuals from each component study and from HapMap II 
were plotted based on the first two eigenvectors produced by the principal 
components analysis.
eQTL analysis. Gene expression information from 776 adipose tissues, 667 
skin tissues and 777 lymphoblastoid cell lines was obtained from the MuTHER 
consortium36. The eQTL data for eight of the ten T2D loci identified in this 
study were available in the MuTHER dataset. Most of those loci passed the 
filtering criteria, such as MAF > 5% and INFO > 0.8, except for rs16955379, 
which has MAF = 1.5% in the MuTHER data set. Two of the ten loci that were 
used in the eQTL analysis, rs6815464 (on chromosome 4) and rs17797882 
(on chromosome 16), are not included in the MuTHER data set. Association 
between each SNP with a significant association to T2D and the normal-
ized mRNA expression values of genes within 1 Mb of the lead SNP were 
performed with the GenABEL and ProbABEL package (see URLs) using the 
polygenic linear model incorporating a kinship matrix in GenABEL followed 
by the ProbABEL mmscore test with imputed genotypes. A multiple-testing 
correction was applied to the cis association results. P value thresholds of 
P = 5.06 × 10−5 in adipose tissue, P = 3.81 × 10−5 in skin and P = 7.80 × 10−5 
in lymphoblastoid cell lines correspond to an estimated genome-wide false 
discovery rate of 1%.
Gene relationships among implicated loci (GRAIL) analysis. A GRAIL 
analysis was performed as described previously31,33. A total of 38 genes within 
T2D-associated regions were selected for the analysis. Among these genes, 
28 were from the previously implicated set (Supplementary Table 3), and 
the other 10 genes were newly implicated in this study (Table 1). PubMed 
abstracts published after December 2006 were omitted from the analysis to 
reduce confounding by results from T2D GWAS.
34. Hyndman, R.J. & Fan, Y. Sample quantiles in statistical packages. Am. Stat. 50, 
361–365 (1996).
35. Devlin, B., Roeder, K. & Wasserman, L. Genomic control, a new approach to genetic-
based association studies. Theor. Popul. Biol. 60, 155–166 (2001).
36. Nica, A.C. et al. The architecture of gene regulatory variation across multiple human 
tissues: the MuTHER study. PLoS Genet. 7, e1002003 (2011).
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